NCT07804901
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07804901
Title Asciminib Frontline Risk Adapted (ARTIST)
Acronym ARTIST
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Prof. Dr. med. Andreas Hochhaus
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Jena Jena 07747 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field